- Home
- FINW vs SCPH Comparison
FINW vs SCPH Comparison
Compare FINW & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- SCPH
- Stock Information
- Founded
- FINW 1999
- SCPH 2013
- Country
- FINW United States
- SCPH United States
- Employees
- FINW N/A
- SCPH N/A
- Industry
- FINW Commercial Banks
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- FINW Finance
- SCPH Health Care
- Exchange
- FINW Nasdaq
- SCPH Nasdaq
- Market Cap
- FINW 261.6M
- SCPH 299.0M
- IPO Year
- FINW 2021
- SCPH 2017
- Fundamental
- Price
- FINW $19.27
- SCPH $5.63
- Analyst Decision
- FINW Buy
- SCPH Buy
- Analyst Count
- FINW 4
- SCPH 3
- Target Price
- FINW $20.75
- SCPH $12.00
- AVG Volume (30 Days)
- FINW 12.0K
- SCPH 2.3M
- Earning Date
- FINW 10-23-2025
- SCPH 11-12-2025
- Dividend Yield
- FINW N/A
- SCPH N/A
- EPS Growth
- FINW N/A
- SCPH N/A
- EPS
- FINW 0.96
- SCPH N/A
- Revenue
- FINW $74,999,000.00
- SCPH $49,969,000.00
- Revenue This Year
- FINW $52.89
- SCPH $108.95
- Revenue Next Year
- FINW $20.66
- SCPH $78.30
- P/E Ratio
- FINW $20.05
- SCPH N/A
- Revenue Growth
- FINW 10.21
- SCPH 107.79
- 52 Week Low
- FINW $13.49
- SCPH $1.94
- 52 Week High
- FINW $20.94
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- FINW 56.14
- SCPH 64.37
- Support Level
- FINW $19.00
- SCPH $4.33
- Resistance Level
- FINW $19.80
- SCPH $5.62
- Average True Range (ATR)
- FINW 0.58
- SCPH 0.05
- MACD
- FINW -0.09
- SCPH 0.01
- Stochastic Oscillator
- FINW 59.23
- SCPH 93.75
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.